NM_000179.3(MSH6):c.706_707del (p.Gln236fs) AND not provided

Germline classification:: Pathogenic (1 submission)
Last evaluated:: Jun 27, 2022
Review status:: 1 star out of maximum of 4 stars
criteria provided, single submitter

Somatic classification of clinical impact:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Somatic classification of oncogenicity:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Record status:: current
Accession:: RCV002508234.1

Allele description [Variation Report for NM_000179.3(MSH6):c.706_707del (p.Gln236fs)]

NM_000179.3(MSH6):c.706_707del (p.Gln236fs)

Gene:

MSH6:mutS homolog 6 [Gene - OMIM - HGNC]

Variant type:

Microsatellite

Cytogenetic location:

2p16.3

Genomic location:

Preferred name:

NM_000179.3(MSH6):c.706_707del (p.Gln236fs)

HGVS:

NC_000002.12:g.47798687CA[1]
NG_007111.1:g.20541CA[1]
NM_000179.3:c.706_707delMANE SELECT
NM_001281492.2:c.316_317del
NM_001281493.2:c.-203CA[1]
NM_001281494.2:c.-203CA[1]
NP_000170.1:p.Gln236fs
NP_001268421.1:p.Gln106fs
LRG_219:g.20541CA[1]
NC_000002.11:g.48025825_48025826del
NC_000002.11:g.48025826CA[1]
NM_000179.2:c.706_707delCA

Protein change:

Q106fs

Links:

dbSNP: rs1553412129

NCBI 1000 Genomes Browser:

rs1553412129

Molecular consequence:

NM_001281493.2:c.-203CA[1] - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
NM_001281494.2:c.-203CA[1] - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
NM_000179.3:c.706_707del - frameshift variant - [Sequence Ontology: SO:0001589]
NM_001281492.2:c.316_317del - frameshift variant - [Sequence Ontology: SO:0001589]

Condition(s)

Synonyms:: none provided
Identifiers:: MedGen: C3661900

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

Help

Submission Accession	Submitter	Review Status (Assertion method)	Clinical Significance (Last evaluated)	Origin	Method	Citations
SCV002817672	GeneDx	criteria provided, single submitter (GeneDx Variant Classification Process June 2021)	Pathogenic (Jun 27, 2022)	germline	clinical testing	Citation Link

Submission Accession

Submitter

Review Status
(Assertion method)

Clinical Significance
(Last evaluated)

Origin

Method

Citations

SCV002817672

GeneDx

criteria provided, single submitter

(GeneDx Variant Classification Process June 2021)

Pathogenic
(Jun 27, 2022)

germline

clinical testing

Citation Link

Help

Summary from all submissions

Ethnicity	Origin	Affected	Individuals	Families	Chromosomes tested	Number Tested	Family history	Method
not provided	germline	yes	not provided	not provided	not provided	not provided	not provided	clinical testing

Details of each submission

From GeneDx, SCV002817672.1

#	Ethnicity	Individuals	Chromosomes Tested	Family History	Method	Citations
1	not provided	not provided	not provided	not provided	clinical testing	not provided

Description

Frameshift variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss of function is a known mechanism of disease; Not observed at significant frequency in large population cohorts (gnomAD); Truncating variants in this gene are considered pathogenic by a well-established clinical consortium and/or database; Has not been previously published as pathogenic or benign to our knowledge

#	Sample				Method		Observation
#	Origin	Affected	Number tested	Tissue	Purpose	Method	Individuals	Allele frequency	Families	Co-occurrences
1	germline	yes	not provided	not provided	not provided		not provided	not provided	not provided	not provided

Last Updated: Oct 8, 2024

ClinVar

Relating variation to medicine